San Francisco, CA, United States of America

Guido Lanza


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Guido Lanza

Introduction

Guido Lanza is a notable inventor based in San Francisco, CA, who has made significant contributions to the field of molecular modeling and treatment methodologies. With a total of five patents to his name, Lanza's work focuses on the intersection of machine learning and biological sciences.

Latest Patents

Lanza's latest patents include groundbreaking inventions such as a method, apparatus, and article of manufacture for modeling the biological effects of molecules. This invention utilizes a machine learning application that processes training examples related to a biological property of interest. Once trained, the application can predict properties for test molecules, enhancing the understanding of molecular interactions. Another significant patent involves compositions and treatments aimed at inhibiting kinase and/or HMG-CoA reductase. This invention provides methods for treating MAP kinase-related and HMG-CoA reductase-related conditions, particularly in inflammatory and cardiovascular contexts.

Career Highlights

Throughout his career, Lanza has worked with prominent companies such as Pharmix Corporation and Numerate, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in the field.

Collaborations

Lanza has collaborated with notable professionals in his field, including Jessen Yu and John H Griffin. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Guido Lanza's contributions to molecular modeling and treatment methodologies exemplify the innovative spirit of modern science. His patents not only advance the understanding of biological effects but also pave the way for new treatment options in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…